Back to newsMyriad Genetics: Stephens raises target price to $6 from $3MMYGN•2026-11-12Stephens raised its target price for Myriad Genetics to $6 from $3.Related NewsNNouveau Monde Graphite swings to third-quarter net income of CAD 7.76 millionNMG•2026-11-12NStifel cuts Nvidia target price to $205 from $315NVDA•2026-11-12HMarineMax holds special shareholder meetingHZO•2026-11-12NNetEase publishes third-quarter 2026 holdings reportNTES•2026-11-12NNETSOL Technologies Inc. Q1 revenue USD 16.4 millionNTWK•2026-11-12